Requiring drug testing for individuals receiving office-based medication-assisted treatment

SB 515 requires drug testing for individuals enrolled in office-based medication-assisted treatment (MAT) programs for substance use disorders in West Virginia. It mandates an initial comprehensive test upon admission, followed by direct observation screening tests every two weeks for six weeks during early treatment, every 45 days for one year during stabilization, and every six months during maintenance. Providers may request additional testing for compliance, with unexpected results requiring confirmatory testing. This bill directly affects patients in MAT programs and their healthcare providers, establishing specific testing schedules under the state's treatment licensing rules.